SIYODE S.A. de C.V. Unimeden

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Heart failure1 trial
• Obesity1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Novo Nordisk A/S2 trials

Running trials

• Recruiting

  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  NCT07797335· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting